Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of L19TNF (onfekafusp alfa) with temozolomide chemoradiotherapy for newly diagnosed glioblastoma patients
GermanyStudy of Pembrolizumab with Standard Chemoradiation for Patients with Advanced Anal Cancer
NorwayStudy on Organ Preservation in Advanced Rectal Cancer Patients Using Bleomycin and Electrochemotherapy After Initial Treatment
ItalyStudy on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers
GermanyStudy on Pain Relief and Recovery After Kidney Removal Surgery Using Ropivacaine, Dexamethasone, and Sodium Chloride in Patients with Renal Cancer
FinlandStudy on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib
ItalyStudy on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment
ItalyStudy of Capecitabine for Patients with Recurrent or Metastatic Salivary Duct Carcinoma
The NetherlandsStudy on Durvalumab and Chemotherapy for Patients with Relapsed Stage III Non-Small Cell Lung Cancer After Chemoradiotherapy and Durvalumab Treatment
ItalyStudy on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain
CyprusComparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk
ItalyStudy on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer
CroatiaThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
